vs
Side-by-side financial comparison of BayCom Corp (BCML) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $25.9M, roughly 1.8× BayCom Corp). BayCom Corp runs the higher net margin — 26.5% vs -4.8%, a 31.3% gap on every dollar of revenue. On growth, BayCom Corp posted the faster year-over-year revenue change (9.4% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $30.1M). Over the past eight quarters, BayCom Corp's revenue compounded faster (2.9% CAGR vs -20.2%).
BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
BCML vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.9M | $47.7M |
| Net Profit | $6.9M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 36.6% | 14.3% |
| Net Margin | 26.5% | -4.8% |
| Revenue YoY | 9.4% | -47.3% |
| Net Profit YoY | 12.1% | -200.9% |
| EPS (diluted) | $0.63 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.9M | $47.7M | ||
| Q3 25 | $25.7M | $122.1M | ||
| Q2 25 | $24.7M | $85.2M | ||
| Q1 25 | $24.3M | $41.1M | ||
| Q4 24 | $23.7M | $90.5M | ||
| Q3 24 | $25.6M | $91.6M | ||
| Q2 24 | $23.8M | $94.4M | ||
| Q1 24 | $24.5M | $74.9M |
| Q4 25 | $6.9M | $-2.3M | ||
| Q3 25 | $5.0M | $40.1M | ||
| Q2 25 | $6.4M | $23.6M | ||
| Q1 25 | $5.7M | $-37.4M | ||
| Q4 24 | $6.1M | $2.3M | ||
| Q3 24 | $6.0M | $3.6M | ||
| Q2 24 | $5.6M | $-860.0K | ||
| Q1 24 | $5.9M | $-4.2M |
| Q4 25 | 36.6% | 14.3% | ||
| Q3 25 | 26.3% | 61.8% | ||
| Q2 25 | 35.3% | 53.2% | ||
| Q1 25 | 31.6% | -70.7% | ||
| Q4 24 | 34.2% | 34.8% | ||
| Q3 24 | 32.4% | 28.0% | ||
| Q2 24 | 31.9% | 26.5% | ||
| Q1 24 | 33.3% | 14.7% |
| Q4 25 | 26.5% | -4.8% | ||
| Q3 25 | 19.5% | 32.8% | ||
| Q2 25 | 25.8% | 27.7% | ||
| Q1 25 | 23.4% | -90.9% | ||
| Q4 24 | 25.9% | 2.5% | ||
| Q3 24 | 23.5% | 4.0% | ||
| Q2 24 | 23.6% | -0.9% | ||
| Q1 24 | 24.0% | -5.6% |
| Q4 25 | $0.63 | $0.01 | ||
| Q3 25 | $0.46 | $0.23 | ||
| Q2 25 | $0.58 | $0.14 | ||
| Q1 25 | $0.51 | $-0.23 | ||
| Q4 24 | $0.55 | $0.03 | ||
| Q3 24 | $0.54 | $0.02 | ||
| Q2 24 | $0.50 | $-0.01 | ||
| Q1 24 | $0.51 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.6M | $-261.8M |
| Total Assets | $2.6B | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | — | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | — | $105.5M | ||
| Q1 24 | — | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $338.6M | $-261.8M | ||
| Q3 25 | $334.3M | $-264.2M | ||
| Q2 25 | $330.6M | $-308.2M | ||
| Q1 25 | $329.3M | $-334.1M | ||
| Q4 24 | $324.4M | $-301.3M | ||
| Q3 24 | $321.7M | $-311.3M | ||
| Q2 24 | $315.3M | $-321.7M | ||
| Q1 24 | $314.2M | $-330.5M |
| Q4 25 | $2.6B | $396.9M | ||
| Q3 25 | $2.6B | $396.1M | ||
| Q2 25 | $2.6B | $342.9M | ||
| Q1 25 | $2.6B | $327.2M | ||
| Q4 24 | $2.7B | $350.9M | ||
| Q3 24 | $2.6B | $389.5M | ||
| Q2 24 | $2.6B | $395.6M | ||
| Q1 24 | $2.6B | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $31.8M | $74.6M |
| Free Cash FlowOCF − Capex | $30.1M | $74.6M |
| FCF MarginFCF / Revenue | 116.2% | 156.3% |
| Capex IntensityCapex / Revenue | 6.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.64× | — |
| TTM Free Cash FlowTrailing 4 quarters | $51.1M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.8M | $74.6M | ||
| Q3 25 | $7.3M | $47.6M | ||
| Q2 25 | $6.4M | $-15.1M | ||
| Q1 25 | $9.3M | $20.0M | ||
| Q4 24 | $30.4M | $15.2M | ||
| Q3 24 | $9.6M | $9.9M | ||
| Q2 24 | $7.7M | $33.5M | ||
| Q1 24 | $5.1M | $45.0M |
| Q4 25 | $30.1M | $74.6M | ||
| Q3 25 | $6.2M | $47.6M | ||
| Q2 25 | $5.6M | $-15.1M | ||
| Q1 25 | $9.1M | $19.9M | ||
| Q4 24 | $28.7M | — | ||
| Q3 24 | $9.4M | $9.9M | ||
| Q2 24 | $7.4M | $33.4M | ||
| Q1 24 | $3.9M | $44.9M |
| Q4 25 | 116.2% | 156.3% | ||
| Q3 25 | 24.3% | 39.0% | ||
| Q2 25 | 22.8% | -17.7% | ||
| Q1 25 | 37.6% | 48.4% | ||
| Q4 24 | 121.1% | — | ||
| Q3 24 | 36.6% | 10.8% | ||
| Q2 24 | 31.2% | 35.4% | ||
| Q1 24 | 16.1% | 60.0% |
| Q4 25 | 6.7% | 0.0% | ||
| Q3 25 | 4.3% | 0.0% | ||
| Q2 25 | 3.0% | 0.0% | ||
| Q1 25 | 0.6% | 0.1% | ||
| Q4 24 | 7.2% | 0.0% | ||
| Q3 24 | 1.0% | 0.0% | ||
| Q2 24 | 1.0% | 0.1% | ||
| Q1 24 | 4.7% | 0.1% |
| Q4 25 | 4.64× | — | ||
| Q3 25 | 1.47× | 1.19× | ||
| Q2 25 | 1.00× | -0.64× | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 4.96× | 6.74× | ||
| Q3 24 | 1.60× | 2.71× | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 0.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
